In biomedical research involving human subjects, research ethics committees around the world have traditionally emphasized individual rights and protections for participants, including informed consent. The emerging field of translational bioethics maintains that the social, economic and psychological implications of pioneering health research—such as gene therapy, xenotransplants and artificial intelligence—should also be considered. Mark A. Rothstein, director of translational bioethics at the University of California, Irvine’s Institute for Clinical and Translational Science, is lead author of a Policy Forum article published recently in Science that explores the matter. For the piece, Read More